BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 19785872)

  • 1. [Interstitial pneumonitis as an adverse effect of thalidomide].
    Scholte JB; Potjewijd J; Voogt PJ; Custers FL; Lie KS
    Ned Tijdschr Geneeskd; 2009; 153():A452. PubMed ID: 19785872
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Interstitial pneumonitis as an adverse effect of thalidomide].
    Scholte JB; Potjewijd J; Voogt PJ; Custers FL; Jie KS
    Ned Tijdschr Geneeskd; 2009; 153():A452. PubMed ID: 20051154
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Interstitial pneumonia during treatment with thalidomide in a patient with multiple myeloma].
    Iguchi T; Sakoda M; Chen CK; Yokoyama K; Hattori Y; Ikeda Y; Okamoto S
    Rinsho Ketsueki; 2004 Sep; 45(9):1064-6. PubMed ID: 15510838
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Case of thalidomide-induced interstitial pneumonia].
    Matsushima H; Oda T; Yamamoto M; Sato A; Hasejima N; Takezawa S
    Nihon Kokyuki Gakkai Zasshi; 2009 May; 47(5):438-42. PubMed ID: 19514509
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lenalidomide-induced interstitial lung disease.
    Chen Y; Kiatsimkul P; Nugent K; Raj R
    Pharmacotherapy; 2010 Mar; 30(3):325. PubMed ID: 20180616
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Thalidomide-induced reversible interstitial pneumonitis in a patient with recurrent ovarian cancer.
    Buttin BM; Moore MJ
    Gynecol Oncol; 2008 Dec; 111(3):546-8. PubMed ID: 18191185
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Two cases of pneumonia caused by Sho-saiko-to].
    Tojima H; Yamazaki T; Tokudome T
    Nihon Kyobu Shikkan Gakkai Zasshi; 1996 Aug; 34(8):904-10. PubMed ID: 8965402
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Side effects and good effects from new chemotherapeutic agents. Case 2. Thalidomide-induced interstitial pneumonitis.
    Onozawa M; Hashino S; Sogabe S; Haneda M; Horimoto H; Izumiyama K; Kondo T; Aldana LP; Hamada K; Asaka M
    J Clin Oncol; 2005 Apr; 23(10):2425-6. PubMed ID: 15800335
    [No Abstract]   [Full Text] [Related]  

  • 9. Leukocytoclastic vasculitis due to thalidomide in multiple myeloma.
    Yildirim ND; Ayer M; Küçükkaya RD; Alpay N; Mete O; Yenerel MN; Yavuz AS; Nalçaci M
    Jpn J Clin Oncol; 2007 Sep; 37(9):704-7. PubMed ID: 17709605
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Thalidomide induced nonspecific interstitial pneumonia in patient with relapsed multiple myeloma.
    Kang MH; Ju JH; Kim HG; Kang JH; Jeon KN; Kim HC; Lee GW
    Korean J Intern Med; 2010 Dec; 25(4):447-9. PubMed ID: 21179284
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interstitial pneumonia caused by inhalation of fumes of nickel and chrome.
    Hisatomi K; Ishii H; Hashiguchi K; Seki M; Ide M; Sugiyama K; Ishimoto H; Nakayama S; Mukae H; Kohno S
    Respirology; 2006 Nov; 11(6):814-7. PubMed ID: 17052314
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Deep vein thrombosis and pulmonary embolism in a patient with multiple myeloma treated with thalidomide and dexamethasone].
    Miyazawa Y; Irisawa H; Uchiumi H; Saitoh T; Handa H; Matsushima T; Tsukamoto N; Karasawa M; Murakami H; Nojima Y
    Rinsho Ketsueki; 2006 Jul; 47(7):656-60. PubMed ID: 16910577
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hypercoagulable states in patients with multiple myeloma can affect the thalidomide-associated venous thromboembolism.
    Talamo GP; Ibrahim S; Claxton D; Tricot GJ; Fink LM; Zangari M
    Blood Coagul Fibrinolysis; 2009 Jul; 20(5):337-9. PubMed ID: 19367157
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Encephalopathy in a patient after long-term treatment with thalidomide.
    Sohlbach K; Heinze S; Shiratori K; Sure U; Pagenstecher A; Neubauer A
    J Clin Oncol; 2006 Oct; 24(30):4942-4. PubMed ID: 17050881
    [No Abstract]   [Full Text] [Related]  

  • 15. Reversible pulmonary toxicity due to lenalidomide.
    Coates S; Barker A; Spurgeon S
    J Oncol Pharm Pract; 2012 Jun; 18(2):284-6. PubMed ID: 21742815
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy and safety of thalidomide in the treatment of multiple myeloma.
    Warzocha K; Kraj M; Pogłód R; Szpila T; Mendek-Czajkowska E; Chełstowska M; Tronina RH
    Acta Pol Pharm; 2008; 65(6):771-4. PubMed ID: 19172865
    [No Abstract]   [Full Text] [Related]  

  • 17. Sustained ventricular tachycardia in a thalidomide-treated patient with primary plasma-cell leukemia.
    Ballanti S; Mastrodicasa E; Bolli N; Lotti F; Capolsini I; Berchicci L; Merigiola C; Giordano G; Tabilio A
    Nat Clin Pract Oncol; 2007 Dec; 4(12):722-5. PubMed ID: 18037876
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reversible dementia due to thalidomide therapy for multiple myeloma.
    Morgan AE; Smith WK; Levenson JL
    N Engl J Med; 2003 May; 348(18):1821-2. PubMed ID: 12724497
    [No Abstract]   [Full Text] [Related]  

  • 19. [A case of interstitial pneumonitis caused by inhalation of cadmium fumes].
    Inoue S; Suzumura Y; Takahashi K
    Nihon Kyobu Shikkan Gakkai Zasshi; 1994 Sep; 32(9):861-6. PubMed ID: 7799556
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Interstitial pneumonitis as a side effect of rituximab].
    Kemming JL; van Zeeland RE; Ullmann EF; Mattijssen EJ
    Ned Tijdschr Geneeskd; 2009; 153():A526. PubMed ID: 19785875
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.